Just a moment, the page is loading...

GSK-101468/219




An open label, randomised, five-way crossover single-dose pharmacokinetic study to assess dosage strength equivalence of ropinirole CR in healthy male and female volunteers
ropinirole
101468/219
Parkinson Disease
Phase 1
A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.
June 2014